These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34294714)

  • 1. CD8
    Koda Y; Teratani T; Chu PS; Hagihara Y; Mikami Y; Harada Y; Tsujikawa H; Miyamoto K; Suzuki T; Taniki N; Sujino T; Sakamoto M; Kanai T; Nakamoto N
    Nat Commun; 2021 Jul; 12(1):4474. PubMed ID: 34294714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8
    Breuer DA; Pacheco MC; Washington MK; Montgomery SA; Hasty AH; Kennedy AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G211-G224. PubMed ID: 31709830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
    Yamato M; Sakai Y; Mochida H; Kawaguchi K; Takamura M; Usui S; Seki A; Mizukoshi E; Yamashita T; Yamashita T; Ishida K; Nasti A; Tuyen HTB; Komura T; Yoshida K; Wada T; Honda M; Kaneko S
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1432-1440. PubMed ID: 30828861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis.
    An P; Wei LL; Zhao S; Sverdlov DY; Vaid KA; Miyamoto M; Kuramitsu K; Lai M; Popov YV
    Nat Commun; 2020 May; 11(1):2362. PubMed ID: 32398673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
    Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
    Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression.
    Du K; Chitneni SK; Suzuki A; Wang Y; Henao R; Hyun J; Premont RT; Naggie S; Moylan CA; Bashir MR; Abdelmalek MF; Diehl AM
    Cell Mol Gastroenterol Hepatol; 2020; 10(1):1-21. PubMed ID: 31881361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell-dependent anti-fibrotic pathway in liver injury via Toll-like receptor-9.
    Abu-Tair L; Axelrod JH; Doron S; Ovadya Y; Krizhanovsky V; Galun E; Amer J; Safadi R
    PLoS One; 2013; 8(12):e82571. PubMed ID: 24340043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auto-aggressive CXCR6
    Dudek M; Pfister D; Donakonda S; Filpe P; Schneider A; Laschinger M; Hartmann D; Hüser N; Meiser P; Bayerl F; Inverso D; Wigger J; Sebode M; Öllinger R; Rad R; Hegenbarth S; Anton M; Guillot A; Bowman A; Heide D; Müller F; Ramadori P; Leone V; Garcia-Caceres C; Gruber T; Seifert G; Kabat AM; Mallm JP; Reider S; Effenberger M; Roth S; Billeter AT; Müller-Stich B; Pearce EJ; Koch-Nolte F; Käser R; Tilg H; Thimme R; Boettler T; Tacke F; Dufour JF; Haller D; Murray PJ; Heeren R; Zehn D; Böttcher JP; Heikenwälder M; Knolle PA
    Nature; 2021 Apr; 592(7854):444-449. PubMed ID: 33762736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Significance of Hepatic CD69
    You Z; Li Y; Wang Q; Zhao Z; Li Y; Qian Q; Li B; Zhang J; Huang B; Liang J; Chen R; Lyu Z; Chen Y; Lian M; Xiao X; Miao Q; Fang J; Lian Z; Eric Gershwin M; Tang R; Ma X
    Hepatology; 2021 Aug; 74(2):847-863. PubMed ID: 33554350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice.
    Chung KJ; Legaki AI; Papadopoulos G; Gercken B; Gebler J; Schwabe RF; Chavakis T; Chatzigeorgiou A
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C.
    Tanwar S; Rhodes F; Srivastava A; Trembling PM; Rosenberg WM
    World J Gastroenterol; 2020 Jan; 26(2):109-133. PubMed ID: 31969775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner.
    Nishizawa H; Iguchi G; Fukuoka H; Takahashi M; Suda K; Bando H; Matsumoto R; Yoshida K; Odake Y; Ogawa W; Takahashi Y
    Sci Rep; 2016 Oct; 6():34605. PubMed ID: 27721459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8
    Muñoz-Durango N; Arrese M; Hernández A; Jara E; Kalergis AM; Cabrera D
    Front Immunol; 2020; 11():563434. PubMed ID: 33391254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis.
    Kim BM; Abdelfattah AM; Vasan R; Fuchs BC; Choi MY
    Sci Rep; 2018 May; 8(1):7499. PubMed ID: 29760499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
    Heinrichs D; Brandt EF; Fischer P; Köhncke J; Wirtz TH; Guldiken N; Djudjaj S; Boor P; Kroy D; Weiskirchen R; Bucala R; Wasmuth HE; Strnad P; Trautwein C; Bernhagen J; Berres ML
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
    Zhong X; Huang M; Kim HG; Zhang Y; Chowdhury K; Cai W; Saxena R; Schwabe RF; Liangpunsakul S; Dong XC
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):341-364. PubMed ID: 32305562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of Hepatic Stellate Cell activation in NASH.
    Marcher AB; Bendixen SM; Terkelsen MK; Hohmann SS; Hansen MH; Larsen BD; Mandrup S; Dimke H; Detlefsen S; Ravnskjaer K
    Sci Rep; 2019 Feb; 9(1):2324. PubMed ID: 30787418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.